[HTML][HTML] Takotsubo syndrome: translational implications and pathomechanisms

X Fan, G Yang, J Kowitz, I Akin, X Zhou… - International journal of …, 2022 - mdpi.com
Takotsubo syndrome (TTS) is identified as an acute severe ventricular systolic dysfunction,
which is usually characterized by reversible and transient akinesia of walls of the ventricle in …

Cardio-onco-hematology in clinical practice. Position paper and recommendations

T Lopez-Fernandez, AM García, AS Beltrán… - Revista Española de …, 2017 - Elsevier
Improvements in early detection and treatment have markedly reduced cancer-related
mortality. However survival not only depends on effectively cure cancer, but prevention …

[HTML][HTML] Takotsubo cardiomyopathy in cancer patients

A Desai, A Noor, S Joshi, AS Kim - Cardio-oncology, 2019 - Springer
Background Cancer is a chronic condition that induces significant emotional and physical
stress, which may increase the risk for developing Takotsubo cardiomyopathy (TCM). Main …

Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones

T López-Fernández, AM García, AS Beltrán… - Revista espanola de …, 2017 - Elsevier
Los avances en la detección precoz y el tratamiento del cáncer han reducido de manera
significativa la mortalidad de los pacientes. Sin embargo, mejorar el pronóstico no es solo …

Drug-induced takotsubo cardiomyopathy

K Kido, M Guglin - Journal of cardiovascular pharmacology …, 2017 - journals.sagepub.com
Background: The most plausible hypothesis for takotsubo cardiomyopathy (TCM) is a
catecholamine surge. Direct administration of catecholamines or medications causing …

[HTML][HTML] Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature

M Coen, F Rigamonti, A Roth, T Koessler - BMC cancer, 2017 - Springer
Background Several chemotherapy molecules, monoclonal antibodies and tyrosine kinase
inhibitors, have been linked to Takotsubo cardiomyopathy (TC). Case presentation In this …

[HTML][HTML] Statin use can attenuate the decline in left ventricular ejection fraction and the incidence of cardiomyopathy in cardiotoxic chemotherapy recipients: a …

J Kim, Y Nishimura, J Kewcharoen, J Yess - Journal of Clinical Medicine, 2021 - mdpi.com
There is insufficient evidence about the cardioprotective effects of statins against
chemotherapy-induced cardiomyopathy. The MEDLINE and EMBASE databases were …

[HTML][HTML] Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review

YK Chae, L Chiec, SK Adney, J Waitzman, R Costa… - Oncotarget, 2018 - ncbi.nlm.nih.gov
As immunotherapies including tyrosine kinase inhibitors become more widely used for the
treatment of a variety of malignancies, it is important for prescribers and patients to …

Chemotherapy-induced takotsubo syndrome

M Budnik, J Kucharz, P Wiechno, T Demkow… - Clinical Pulmonary …, 2018 - Springer
Cardiovascular complications are a significant problem in systemically treated cancer
patients. One such complication is Takotsubo cardiomyopathy, also known as Takotsubo …

Drugs as possible triggers of Takotsubo cardiomyopathy: a comprehensive literature search–update 2015

P Amariles, L Cifuentes - Current clinical pharmacology, 2016 - ingentaconnect.com
Background: In 2011 a list of 20 drugs linked to drug-induced Tako-Tsubo cardiomyopathy
(TCM) was published. Thus, the objectives were both to identify cases of drug-induced TCM …